Macroview Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-100
| Closed | -$6.82K | – | 609 |
|
|
2024
Q1 | $6.82K | Sell |
100
-113
| -53% | -$7.7K | 0.01% | 353 |
|
|
2023
Q4 | $13.3K | Buy |
213
+113
| +113% | +$7.07K | 0.02% | 214 |
|
|
2023
Q3 | $4.54K | Sell |
100
-15
| -13% | -$681 | 0.01% | 449 |
|
|
2023
Q2 | $6.46K | Buy |
115
+100
| +667% | +$5.62K | 0.01% | 312 |
|
|
2023
Q1 | $679 | Hold |
15
| – | – | ﹤0.01% | 396 |
|
|
2022
Q4 | $610 | Hold |
15
| – | – | ﹤0.01% | 412 |
|
|
2022
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 364 |
|
|
2022
Q2 | $1K | Hold |
15
| – | – | ﹤0.01% | 389 |
|
|
2022
Q1 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 373 |
|